Nonalcoholic fatty liver disease (NAFLD) is now recognized as the most common cause of
chronic liver disease worldwide. Its prevalence has increased to more than 30% of adults in …

Non-alcoholic fatty liver disease (NAFLD) is a growing cause of chronic liver disease
worldwide. It is characterised by steatosis, liver inflammation, hepatocellular injury and …

Non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH) has become the leading
cause of liver disease worldwide. NASH, an advanced form of NAFL, can be progressive …

Non-alcoholic fatty liver disease affects approximately one-third of the population worldwide,
and its incidence continues to increase with the increasing prevalence of other metabolic …

The occurrence of nonalcoholic fatty liver disease (NAFLD) is associated with major
abnormalities of hepatic lipid metabolism. We propose that lipid abnormalities directly or …

Non-alcoholic steatohepatitis (NASH) is a chronic and progressive form of non-alcoholic
fatty liver disease (NAFLD). Its global incidence is increasing which makes NASH an …

Nonalcoholic steatohepatitis (NASH) has become a major cause of cirrhosis and liver-
related deaths worldwide. NASH is strongly associated with obesity and the metabolic …

The worldwide prevalence of non-alcoholic fatty liver disease (NAFLD) is estimated to have
reached 25% or more in adults. NAFLD is prevalent in obese individuals, but may also affect …

The prevalence of nonalcoholic steatohepatitis (NASH) is increasing worldwide, yet there
are no effective treatments. A decade has passed since the initial lipidomics analyses of liver …

Nonalcoholic fatty liver disease (NAFLD) has emerged as a serious obesity-related disorder.
NAFLD encompasses a wide spectrum of hepatic derangements ranging from a surfeit of fat …